As per the research report, the Latin America Lateral Flow Assay Market size is forecasted to worth USD Million by 2027 from USD 922.63 Million in 2024, growing at an 8.76% CAGR from 2024 to 2029.
Lateral flow assays (LFAs) are the technology behind low-cost, simple, rapid, and portable detection devices popular in biomedicine, agriculture, food, and environmental sciences. Lately, these types of assays have attracted considerable attention due to their potential to provide an immediate diagnosis to patients. The variety and interpretation of these results and parameters are used for the assessment of the assay.
The lateral flow assay test market is anticipated to witness positive growth due to high incidences of infectious and communicable diseases and an increase in rapid testing in-home care settings. Moreover, an increase in the geriatric population, a rise in lateral flow assay in clinical laboratory practice, an increase in chronic diseases, and technology advancements are expected further to boost the market growth in the coming years.
However, the increase in regulations and inconsistency in test results may pose a restrain to the lateral flow assay market in the coming years.
Geographically, the market offers high potential due to governmental initiatives, improved healthcare infrastructure,, and an increasedand for quality care at affordable prices.
Prominent companies leading in the Latin America Lateral Flow Assay Market profiled in the report are Alere Inc., F. Hoffmann-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Johnson & Johnson, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., and PerkinElmer Inc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region